Advanced Manufacturing Growth Investors & VC Firms
796 firms in this list, with a median first check of $3M. 213 of them lead rounds. Generated from verified public data and updated continuously.
Marunouchi Innovation Partners
TokyoSeries B–Growth
30 people
Kilonova Capital
San FranciscoGrowth–Late Stage$25M – $150M
30 people
Third Point Ventures
Menlo ParkSeed–Late Stage
6 people
Hamilton Lane
ConshohockenGrowth
17 people
Lincolnshire
New YorkGrowth
29 people
CFH Management GmbH
LeipzigSeed–Growth$108K – $5.4M
27 people
Genesis Capital Equity s.r.o.
PragueGrowth$1M – $35M
30 people
Rockaway Capital
PragueGrowth$500M – $2B
27 people
Chevron Technology Ventures
HoustonSeed–Growth
19 people
HG Ventures
IndianapolisSeed–Growth$1M – $10M
12 people
White Summit Capital Management SGEIC
ZugGrowth
27 people
Capiton AG
BerlinGrowth–Late Stage
29 people
Impact Bridge Asset Management SGIIC SA
MadridGrowth$1M – $50M
29 people
Bascom Ventures
ManchesterPre-Seed–Late Stage
7 people
Ccmp
New YorkGrowth$50M – $200M
22 people
Frontline Strategy Funds
SingaporeSeed–Growth$5M – $15M
13 people
Leonid Capital Partners
WashingtonSeed–Growth
28 people
Amicus Capital Partners
BangaloreGrowth
22 people
Enterprise Investors Sp. z o. o.
WarsawSeries B–Growth$21.6M – $81M
27 people
CID Capital
CarmelSeed–Growth$10M
17 people
Nordian Capital
AmsterdamGrowth
17 people
Prysm Capital
San FranciscoGrowth
19 people
Anti
San JuanPre-Seed–Growth$250K – $30M
6 people
Industrial Technology Investment Corporation
TaipeiPre-Seed–Late Stage
15 people
Related lists
Growth Investors & VC Firms (4561)Growth Investors & VC Firms in North America (2360)Advanced Manufacturing Investors & VC Firms (2063)Growth Investors & VC Firms in United States (2055)Growth Investors & VC Firms in Europe (1814)Growth Investors & VC Firms in Global (1565)Healthtech Growth Investors & VC Firms (1464)Advanced Manufacturing Seed Investors & VC Firms (1408)Fintech Growth Investors & VC Firms (1400)Growth Investors & VC Firms in Asia-Pacific (1343)
Data sourced from public filings and firms' own websites — see our methodology.








































































































